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this interface is distinct from the one
observed in recently reported conven-
tional EAL structures. Interestingly, c-di-
GMP binding and formation of this dimer
appear to be mutually exclusive, owing
to potential clashes between the nucleo-
tide and the dimeric conformations.
Therefore, Navarro et al. (2009) postulate
that this interface might be used for inter-
action with other still unidentified part-
ners, possibly EAL-containing proteins.
Binding of c-di-GMP could relieve the
interaction, making either FimX or another
EAL protein ready for subsequent func-
tions. However, it is still not clear how
the SAXS model of the full-length FimX
dimer fits into this mechanism and
whether the N-terminal REC and PAS
domains play any role in the c-di-GMP-
dependent regulation, as might be ex-
pected because dimerization via the
REC domains has been shown to be
important for regulation of enzyme activity
in some GGDEF and EAL domains (Rao
et al., 2009; Wassmann et al., 2007).
Multiplicity and diversity of GGDEF and
EAL proteins greatly contribute to the
complexity of c-di-GMP signaling. Many
catalytically inactive degenerate domains
are being recognized as essential compo-
nents of c-di-GMP regulatory networks,
and continuing efforts have been made
to identify the sequence signatures for
binding, synthesis, and degradation of
c-di-GMP molecules. This study provides
a first step in the characterization of de-
generate GGDEF and EAL proteins and
allows postulation of mechanistic models
for regulation. However, great caution
should be taken in extrapolating the regu-
latory details of one protein to other
members of the family. GGDEF and EAL
domains have low sequence identity
within their families and appear highly
plastic in regards to protein-protein inter-
actions. Similar to the versatile regulatory
mechanisms that occur in the other major
bacterial signaling strategy, two-compo-
nent phosphotransfer systems (Gao and
Stock, 2009), diverse regulation methods
are expected in c-di-GMP signaling.
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SH2 domains are phosphotyrosine specific interaction modules with largely overlapping sequence specific-
ities. A recent structure by Bae et al. revealed that SH2 domain specificity can be mediated by secondary
binding sites located outside the phosphotyrosine binding pocket.
Open access under CC BY license.Selective recognition of phosphotyrosine
(pY) signals by small modular binding
domains is a fundamental principle of
cellular signaling. The Src homology 2
(SH2) domain is the most prevalent of the
pY specific signalingmodules. The human
genome contains 120 SH2 domains pres-1040 Structure 17, August 12, 2009 ª2009 Eent in 110 signaling molecules, which play
a central role in the regulation of tyrosine
kinase signaling pathways (Liu et al.,
2006). Directed phosphopeptide library
screening revealed the sequence speci-
ficity of most SH2 domains and showed
that amino acids located from 2 to +4lsevier Ltd All rights reservedrelative to the pY contribute to selectivity
and high affinity binding of peptidic sub-
strates (Songyang et al., 1993). However,
these studies also revealed that a multi-
tude of pY-containing sequences can be
recognized by several SH2 domains with
similar affinity in vitro. Many signaling
Structure
Previewsmolecules contain more than one interac-
tion module, suggesting that cooperative
binding of several binding events will pro-
vide selectivity of signaling in vivo. How-
ever, trying to explain the selectivity of
signaling processes with the specificity
of SH2 domain pY binding sites would be
an oversimplification of the complex inter-
actions in cellular signalosomes.
The family of fibroblast growth factor
receptors (FGFRs) represents four recep-
tor tyrosine kinases that recruit a number
of signaling partners to the plasma mem-
brane as a response to FGF stimulation.
A key FGFR interaction partner is phos-
pholipase Cg (PLCg), which interacts via
its SH2 domain with the highly conserved
C-terminal tail residueY766 (FGFR1).How-
ever, PLCg possesses two SH2 domains
(N-SH2 and C-SH2: N- and C-terminal
SH2 domains) that recognize the same
substrates and have similar binding
affinity for pY peptides derived from the
FGF1R tail as well as other sites located
in PDGFR and other RTKs (Ji et al.,
1999). Binding studies in growth factor
stimulated cells showed that only the
PLCg N-SH2, but not C-SH2, binds to pY
sites present in RTK tails, whereas the
C-SH2 binds intramolecularly to pY783
stimulating phospholipase activity by sta-
bilizing a structural rearrangement in
PLCg (Poulin et al., 2005).
Interestingly, the recent crystal structure
of a complex of the two PLCg SH2
domains with active FGFR1 showed that
a high affinity interaction of N-SH2 with
FGFR1 ismediatedbyasecondarybinding
site located outside the SH2 domain pY
binding site (Bae et al., 2009). Bae et al.
(2009) showed, by a combination of struc-
tural, mutagenesis, and binding studies,
how the SH2 domain selectivity is regu-
lated in vivo to mediate a specific cellular
process and explains the selectivity for
N-SH2 for the FGFR1 C-terminal tail.
The detailed structural analysis re-
vealed that, as expected, the N-SH2 do-main is bound to the pY766LDL sequence
within the C-terminal tail of FGFR1-3P,
whereas the C-SH2 binding site is unoc-
cupied and exposed to the solvent, allow-
ing additional intramolecular interaction
with pY783 upon the PLCg activation.
The identified secondary binding site is
located distantly from the N-SH2 pY site
interacting with the C-terminal kinase
lobe. In N-SH2, the secondary interaction
site comprises residues located in the
stands bD, the loops BC and DE interact-
ing with FGF1R residues in the helices aE
and aI, and the sheet b8. This interaction
covers 533 A˚2, a surface area that is
comparable with the area covered by the
primary pY interaction site. The sec-
ondary pocket consists of two subsites
with different surface properties. The first
subsite is mainly hydrophobic and forms
several van der Waals contacts with
FGFR1 residues V758, A759, V636. and
hydrophobic areas of the sidechains
Q606 and D755. The second subsite con-
tains mainly charged residues forming
polar interactions with FGF1R, as exem-
plified by polar interactions between
R609 in FGFR1 aE with PLCg D594 and
the carbonyl oxygen of S612. Importantly,
in contrast to the pY binding sites, resi-
dues located in the secondary binding
site of N-SH2 that mediate interaction
with FGF1R are highly divergent from
residues in corresponding positions in
C-SH2, explaining the observed selec-
tivity for the N-terminal domain in vivo.
The presence of the secondary binding
site in N-SH2 also increases the binding
strength significantly. Isothermal titration
calorimetry experiments showed that the
N-SH2 binds 10–40 times more tightly
to the kinase domain of activated FGF1R
(FGF1R-3P) than to pY peptides lowering
the dissociation constant to 33 nM.
Importantly, mutagenesis experiments
revealed that interactions mediated by
the secondary binding site are required
for stimulation of phosphatidylinositol-Structure 17, August 12, 20094,5-biphosphate hydrolysis in FGF-stimu-
lated cells.
Bae et al. (2009) report an important
finding that provides additional insight
and enhances our understanding of the
specificity of pY signaling cascades and
demonstrates that SH2 domains are ver-
satile and complex signaling modules
that can also mediate interactions outside
their pY binding pocket. Furthermore, re-
cent structural studies revealed that inter-
actions mediated outside the pY pocket
of SH2 domains are essential for main-
taining the active state of the tyrosine
kinases Csk, cAbl, and Fes (Filippakopou-
los et al., 2008; Ogawa et al., 2002). These
observations open an interesting area for
future structural and functional studies
that will elucidate the molecular mecha-
nisms that determine the high degree of
specificity of in vivo signaling events.
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